Bio/Pharmaceutical Analysis, Gas Chromatography

Instrumentation advancements over the past 30 years have certainly enabled greater efficiency in pharma development and analysis despite slow adoption by the industry.

As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.

Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.

CEM reports that the EDGE extraction system for rapid sample preparation of gas chromatography/liquid chromatography samples from CEM can prepare samples for molecular analysis within 5 min.

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.

Join experts from SGS and Thermo Fisher Scientific to hear how to improve workflows for confident extractable and leachable studies. Live: North America: Tuesday, Oct. 31, 2017 | 11am EDT | 10am CDT / Europe: Tuesday, 7 Nov., 2017 | 9am GMT | 10am CET / On Demand available after airing until 7 Nov., 2018. Register free: http://www.pharmtech.com/pt_w/analytical

The past several months have seen new product releases and updates made to already available laboratory equipment.

Phenomenex opened a new manufacturing and development facility in CA for the company’s gas chromatography columns.

Solid-phase extraction has several advantages over liquid/liquid extraction for extractables and leachables studies.

Agilent’s new facility in Folsom, California includes laboratory, order fulfilment, and warehousing space.

The Chinese facility was cited for data integrity violations.

Process analytical technology paved the way for continuous manufacturing.

USP 467 Residual Solvents will take effect on July 1, 2008. But does the industry understand these specifications-and is it prepared?